Adaptin Bio (APTN) Invested Capital (2022 - 2026)

Adaptin Bio's Invested Capital history runs 5 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• In Q1 2026, Invested Capital fell 187.95% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$1.5 million (down 187.95% YoY), while the FY2025 annual figure was -$1.5 million, up 47.77% from the prior year.
• Invested Capital came in at -$1.5 million for Q1 2026 at Adaptin Bio, down from -$1.5 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.7 million in Q1 2025 to a low of -$3.2 million in Q3 2024.
• A 5-year average of -$884574.6 and a median of -$929318.5 in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital slumped 5865.06% in 2024 and jumped 232.52% in 2025, its largest moves.
• Adaptin Bio's Invested Capital stood at -$27304.0 in 2022, then tumbled by 3480.28% to -$977559.0 in 2023, then slumped by 191.69% to -$2.9 million in 2024, then surged by 47.77% to -$1.5 million in 2025, then dropped by 3.05% to -$1.5 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$1.5 million, -$1.5 million, and -$881078.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison